XML 51 R38.htm IDEA: XBRL DOCUMENT v3.19.1
Note 8 - Segment Information and Dissaggregated Revenue - Operations by Business Segment (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2017
Mar. 31, 2019
Mar. 31, 2018
Sales, net $ 14,088 $ 10,575   $ 36,393 $ 31,145
Gross Profit 2,093 1,469   4,643 3,522
Depreciation 69 57 $ 57 201 189
Capital Expenditures 63 42   350 258
Contract Manufacturing [Member]          
Sales, net 13,788 10,212   35,396 29,975
Gross Profit 1,995 1,363   4,323 3,094
Depreciation 68 55   199 184
Capital Expenditures 63 42   350 244
Branded Proprietary Products [Member]          
Sales, net 17 9   155 211
Gross Profit 7 (2)   49 95
Depreciation 1   3
Capital Expenditures   13
Other Nutraceutical Business [Member]          
Sales, net 283 354   842 959
Gross Profit 92 108   271 333
Depreciation 1 1   2 2
Capital Expenditures   1
UNITED STATES          
Sales, net 12,210 9,684   32,002 27,348
UNITED STATES | Contract Manufacturing [Member]          
Sales, net 11,913 9,333   31,066 26,314
UNITED STATES | Branded Proprietary Products [Member]          
Sales, net 14   133 181
UNITED STATES | Other Nutraceutical Business [Member]          
Sales, net 283 351   803 853
Non-US [Member]          
Sales, net 1,878 891   4,391 3,797
Non-US [Member] | Contract Manufacturing [Member]          
Sales, net 1,875 879   4,330 3,661
Non-US [Member] | Branded Proprietary Products [Member]          
Sales, net 3 9   22 30
Non-US [Member] | Other Nutraceutical Business [Member]          
Sales, net $ 3   $ 39 $ 106